EDSA
Biotechnology · Healthcare
Chairman, Board Member
2019-01-01–present
Chairman
Edesa Biotech, Inc. (EDSA)Board Member
Edesa Biotech, Inc. (EDSA)Equibles does not estimate personal net worth.
Get an email with a short summary when Edesa Biotech, Inc. publishes a filing, an earnings call transcript or a press release.
Get EDSA alertsCarlo Sistilli is recorded as Board Member at Edesa Biotech, Inc. (EDSA) since January 1, 2019 and Chairman at Edesa Biotech, Inc. (EDSA). The newest filing on record that lists Carlo Sistilli as Chairman and Board Member at Edesa Biotech, Inc. (EDSA) is dated April 3, 2026. Edesa Biotech, Inc. reported in an 8-K filed May 29, 2026 that Carlo Sistilli was appointed member of the Company's board of directors, effective May 27, 2026. Edesa Biotech, Inc. reported in an 8-K filed May 28, 2025 that Carlo Sistilli was appointed Director, effective May 28, 2025. Edesa Biotech, Inc. reported in an 8-K filed May 30, 2024 that Carlo Sistilli was appointed Director, effective May 30, 2024. Equibles holds 4 filed executive changes naming Carlo Sistilli; each is listed under recent activity with its source filing. Edesa Biotech, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Edesa Biotech, Inc. includes Pardeep Nijhawan (CEO and Board Member), Peter J. Weiler (CFO), Peter Weiler (CFO) and 7 others.
“the shareholders elected Joan Chypyha, David Liu, Sean MacDonald, Patrick Marshall, Pardeep Nijhawan, Charles Olson and Carlo Sistilli to serve as members of the Company's board of directors until the annual meeting of shareholders to be held in 2027 or until their successors are duly elected and qualified.”
“the shareholders elected Joan Chypyha, David Liu, Sean MacDonald, Patrick Marshall, Pardeep Nijhawan, Charles Olson and Carlo Sistilli to serve as members of the Company's board of directors until the annual meeting of shareholders to be held in 2026 or until their successors are duly elected and qualified.”
2019-01-01–present
Last confirmed April 3, 2026
Start not stated–present
Last confirmed April 3, 2026
EDSA
Biotechnology · Healthcare
Chairman, Board Member
2019-01-01–present